| Trial Identifier: | D8530C00003 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT04588298 |
| Start Date: | November 2020 |
| Primary Completion Date: | June 2023 |
| Study Completion Date: | June 2023 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Spanish (Mexico) Translation | |
| Georgian Translation |
| Country | Location |
|---|---|
| GB | Derby, GB, DE22 3NE |
| GB | Leicester, GB, LE1 5WW |
| GB | Liverpool, GB, L7 8XP |
| GB | London, GB, W12 0HS |
| GB | Manchester, GB, M23 9LT |
| GE | Batumi, GE, 6000 |
| GE | Tbilisi, GE, 0179 |
| GE | Tbilisi, GE, '0112 |
| GE | Tbilisi, GE, 0159 |
| GE | Tbilisi, GE, '0186 |
| MX | Aguascalientes, MX, 20230 |
| MX | Mexico City, MX, '14080 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company